
Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV
Author(s) -
Jovana Milić,
Valentina Menozzi,
Filippo Schepis,
Andrea Malagoli,
Giulia Besutti,
Iacopo Franconi,
Alessandro Raimondi,
Federica Carli,
Cristina Mussini,
Giada Sebastiani,
Giovanni Guaraldi
Publication year - 2020
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002650
Subject(s) - medicine , steatosis , nonalcoholic fatty liver disease , gastroenterology , cirrhosis , fatty liver , fibrosis , diabetes mellitus , liver disease , metabolic syndrome , odds ratio , obesity , disease , endocrinology
The aim was to investigate the contribution of liver steatosis and significant fibrosis alone and in association [nonalcoholic fatty liver disease (NAFLD) with fibrosis] to frailty as a measure of biological age in people living with HIV (PLWH).